Financial & competing interests disclosure
The views expressed in this report are exclusively the author's (HSS) own opinion based on current scientific literature and available knowledge so far. These views in no way represent the official opinion of any organization mentioned above or Uppsala University. The author's research on nanoparticles is partly supported by European Office of Aerospace Research and Development (EOARD), US Air Force, London Office, UK; AstraZeneca, Mölndal, Sweden, Uppsala University, Uppsala, Sweden, Global College of Neuroprotection and Neuroregeneration (GCNN), UK, Ebewe Pharma, Austria, and Society for Study on Neuroproetction and Neuroplasticity (SSNN, Cluj, Romania). However, the author (HSS) has no conflict of interest with any organization or the pharmaceutical companies listed above for his research or his association with Uppsala University.